Jury award in Fosamax/ONJ case cut from $8M to $1.5M
A federal judge has ruled that Merck must now pay only $1.5 million in compensatory damages to Shirley Boles, a 72-year-old woman who claimed the company’s bisphosphonate drug Fosamax caused her to develop osteonecrosis of the jaw (ONJ) and related dental problems. Boles’ original lawsuit ended in a mistrial in September 2009, but in a retrial in June of this year, a New York jury found in favor of Boles,

